Literature DB >> 16421629

Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and behavioral disorders.

Su-Jane Wang1, Tsung-Tsair Yang.   

Abstract

Glutamate is the most ubiquitous of the fast excitatory neurotransmitters in the central nervous system. In the process, glutamate fulfills numerous physiological functions, but also plays an important role in the pathophysiology of a variety of psychiatric and behavioral disorders such as schizophrenia. Recently, modulation of glutamatergic neurotransmission has been suggested to be involved in the mechanisms of action of antipsychotic drugs. Thus, pharmacological manipulation of glutamatergic transmission may be a feasible therapeutic strategy for treatment of schizophrenia. In this review article, we focus on the role of central glutamatergic neurotransmission in the pathogenesis and pharmacotherapy of schizophrenia and the development of new drugs targeting glutamate brain systems. 2005 Prous Science

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16421629     DOI: 10.1358/dnp.2005.18.9.953668

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  2 in total

1.  Jian-Pi-Zhi-Dong-Decoction regulates the expression of glutamate transporters to attenuate glutamate excitotoxicity and exerts anti-tics effects in Tourette syndrome model rats.

Authors:  Wenjing Yu; Xiaowei Shi; Xia Cui; Yan Niu; Wen Zhang; Xue Bai; Qian Wang; Lijun Hu; Sumei Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-17       Impact factor: 2.570

2.  Energy Drink Administration in Combination with Alcohol Causes an Inflammatory Response and Oxidative Stress in the Hippocampus and Temporal Cortex of Rats.

Authors:  Alfonso Díaz; Samuel Treviño; Jorge Guevara; Guadalupe Muñoz-Arenas; Eduardo Brambila; Blanca Espinosa; Albino Moreno-Rodríguez; Gustavo Lopez-Lopez; Ulises Peña-Rosas; Berenice Venegas; Anabella Handal-Silva; José Luis Morán-Perales; Gonzalo Flores; Patricia Aguilar-Alonso
Journal:  Oxid Med Cell Longev       Date:  2016-03-16       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.